Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction: Cardiovascular Effects.

NCT05236335 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Aarhus